Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 25.91
(0.0%)
USD 25.91
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 522.6 Million NZD | 15.85% |
| 2023 | 451.1 Million NZD | 5.57% |
| 2022 | 427.3 Million NZD | -22.88% |
| 2021 | 554.1 Million NZD | 20.14% |
| 2020 | 461.2 Million NZD | 57.14% |
| 2019 | 293.5 Million AUD | 11.3% |
| 2018 | 263.7 Million AUD | 21.76% |
| 2017 | 216.56 Million AUD | -3.81% |
| 2016 | 225.13 Million AUD | 13.35% |
| 2015 | 198.62 Million AUD | -11.41% |
| 2014 | 224.2 Million AUD | -9.0% |
| 2013 | 246.36 Million AUD | 10.03% |
| 2012 | 223.9 Million AUD | 9.59% |
| 2011 | 204.31 Million AUD | 12.33% |
| 2010 | 181.89 Million AUD | -13.15% |
| 2009 | 209.43 Million AUD | 53.99% |
| 2008 | 136 Million AUD | 67.59% |
| 2007 | 81.15 Million AUD | 27.85% |
| 2006 | 63.47 Million AUD | 65.83% |
| 2005 | 38.27 Million AUD | 16.18% |
| 2004 | 32.94 Million AUD | -8.31% |
| 2003 | 35.93 Million AUD | -17.3% |
| 2002 | 43.45 Million AUD | -48.64% |
| 2001 | 84.59 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 522.6 Million NZD | 15.85% |
| 2024 Q4 | 522.6 Million NZD | 0.0% |
| 2024 Q2 | 638 Million NZD | 8.51% |
| 2024 Q1 | 587.95 Million NZD | 30.34% |
| 2023 Q4 | 451.1 Million NZD | 7.21% |
| 2023 FY | 451.1 Million NZD | 5.57% |
| 2023 Q1 | 557.3 Million NZD | 30.43% |
| 2023 Q2 | 616.1 Million NZD | 10.55% |
| 2023 Q3 | 420.76 Million NZD | -31.71% |
| 2022 Q4 | 427.3 Million NZD | 0.0% |
| 2022 FY | 427.3 Million NZD | -22.88% |
| 2021 Q4 | 554.1 Million NZD | 0.0% |
| 2021 FY | 554.1 Million NZD | 20.14% |
| 2020 Q4 | 461.2 Million NZD | 0.0% |
| 2020 FY | 461.2 Million NZD | 57.14% |
| 2019 Q4 | 293.5 Million AUD | 0.0% |
| 2019 FY | 293.5 Million AUD | 11.3% |
| 2018 FY | 263.7 Million AUD | 21.76% |
| 2018 Q4 | 263.7 Million AUD | 0.0% |
| 2017 Q4 | 216.56 Million AUD | 0.0% |
| 2017 FY | 216.56 Million AUD | -3.81% |
| 2016 FY | 225.13 Million AUD | 13.35% |
| 2016 Q4 | 225.13 Million AUD | 0.0% |
| 2015 FY | 198.62 Million AUD | -11.41% |
| 2015 Q4 | 198.62 Million AUD | 0.0% |
| 2014 Q4 | 224.2 Million AUD | 0.0% |
| 2014 FY | 224.2 Million AUD | -9.0% |
| 2013 FY | 246.36 Million AUD | 10.03% |
| 2013 Q4 | 246.36 Million AUD | 0.0% |
| 2012 Q4 | 223.9 Million AUD | 0.0% |
| 2012 FY | 223.9 Million AUD | 9.59% |
| 2011 Q4 | 204.31 Million AUD | 0.0% |
| 2011 FY | 204.31 Million AUD | 12.33% |
| 2010 Q4 | 181.89 Million AUD | 0.0% |
| 2010 FY | 181.89 Million AUD | -13.15% |
| 2009 FY | 209.43 Million AUD | 53.99% |
| 2009 Q4 | 209.43 Million AUD | 0.0% |
| 2008 FY | 136 Million AUD | 67.59% |
| 2008 Q4 | 136 Million AUD | 0.0% |
| 2007 Q4 | 81.15 Million AUD | 0.0% |
| 2007 FY | 81.15 Million AUD | 27.85% |
| 2006 FY | 63.47 Million AUD | 65.83% |
| 2006 Q4 | 63.47 Million AUD | 0.0% |
| 2005 FY | 38.27 Million AUD | 16.18% |
| 2005 Q4 | 38.27 Million AUD | 0.0% |
| 2004 Q4 | 32.94 Million AUD | 0.0% |
| 2004 FY | 32.94 Million AUD | -8.31% |
| 2003 Q4 | 35.93 Million AUD | 0.0% |
| 2003 FY | 35.93 Million AUD | -17.3% |
| 2002 FY | 43.45 Million AUD | -48.64% |
| 2001 FY | 84.59 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -22139.774% |
| Ansell Limited | 1.32 Billion USD | 60.704% |
| Ansell Limited | 1.33 Billion USD | 60.778% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -313.653% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -55308.77% |
| Psykey, Inc. | 2.47 Million USD | -21023.524% |
| ConvaTec Group Plc | 2.01 Billion USD | 74.105% |
| ConvaTec Group Plc | 2.02 Billion USD | 74.142% |
| Encision Inc. | 1.98 Million USD | -26241.151% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -17088.081% |
| Innovative MedTech Inc. | 6.13 Million USD | -8418.555% |
| LifePoint, Inc. | 2.45 Million USD | -21194.377% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -5033.091% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -15270.588% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -17088.963% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -67216.821% |
| SmileDirectClub, Inc. | 982.26 Million USD | 46.796% |
| Sector 10, Inc. | 9.84 Million USD | -5208.048% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 61.452% |
| SheerVision, Inc. | 1.43 Million USD | -36409.634% |
| United Health Products, Inc. | 1.99 Million USD | -26044.785% |
| Vasamed, Inc. | 1 Million USD | -51884.482% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -13651.6% |
| Yubo International Biotech Limited | 2.91 Million USD | -17834.579% |